Trastuzumab biosimilar for HER2-positive breast and gastric carcinoma

被引：0
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷 / 09期
关键词：
D O I：
10.1159/000502727
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：482 / 483
页数：2
相关论文
共 9 条
  • [1] [Anonymous], 2018, FACHINFORMATION OGIV
  • [2] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
    Cortazar, Patricia
    Zhang, Lijun
    Untch, Michael
    Mehta, Keyur
    Costantino, Joseph P.
    Wolmark, Norman
    Bonnefoi, Herve
    Cameron, David
    Gianni, Luca
    Valagussa, Pinuccia
    Swain, Sandra M.
    Prowell, Tatiana
    Loibl, Sibylle
    Wickerham, D. Lawrence
    Bogaerts, Jan
    Baselga, Jose
    Perou, Charles
    Blumenthal, Gideon
    Blohmer, Jens
    Mamounas, Eleftherios P.
    Bergh, Jonas
    Semiglazov, Vladimir
    Justice, Robert
    Eidtmann, Holger
    Paik, Soonmyung
    Piccart, Martine
    Sridhara, Rajeshwari
    Fasching, Peter A.
    Slaets, Leen
    Tang, Shenghui
    Gerber, Bernd
    Geyer, Charles E., Jr.
    Pazdur, Richard
    Ditsch, Nina
    Rastogi, Priya
    Eiermann, Wolfgang
    von Minckwitz, Gunter
    [J]. LANCET, 2014, 384 (9938) : 164 - 172
  • [3] Dicheva-Radev S, 2018, KOMPENDIUM BIOSIMILA, V3, P7
  • [4] Lipp HP, 2016, KOMPENDIUM BIOSIMILA, V1, P33
  • [5] Ludwig WD, 2017, KOMPENDIUM BIOSIMILA, V2, P7
  • [6] Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer A Randomized Clinical Trial
    Rugo, Hope S.
    Barve, Abhijit
    Waller, Cornelius F.
    Hernandez-Bronchud, Miguel
    Herson, Jay
    Yuan, Jinyu
    Sharma, Rajiv
    Baczkowski, Mark
    Kothekar, Mudgal
    Loganathan, Subramanian
    Manikhas, Alexey
    Bondarenko, Igor
    Mukhametshina, Guzel
    Nemsadze, Gia
    Parra, Joseph D.
    Abesamis-Tiambeng, Maria Luisa T.
    Baramidze, Kakhaber
    Akewanlop, Charuwan
    Vynnychenko, Ihor
    Sriuranpong, Virote
    Mamillapalli, Gopichand
    Ray, Sirshendu
    Yanez Ruiz, Eduardo P.
    Pennella, Eduardo
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01): : 37 - 47
  • [7] Rugo HS, ESMO 2018
  • [8] Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
    Tabernero, Josep
    Vyas, Malvika
    Giuliani, Rosa
    Arnold, Dirk
    Cardoso, Fatima
    Casali, Paolo G.
    Cervantes, Andres
    Eggermont, Alexander M. M.
    Eniu, Alexandru
    Jassem, Jacek
    Pentheroudakis, George
    Peters, Solange
    Rauh, Stefan
    Zielinski, Christoph C.
    Stahel, Rolf A.
    Voest, Emile
    Douillard, Jean-Yves
    McGregor, Keith
    Ciardiello, Fortunato
    [J]. ESMO OPEN, 2016, 1 (06)
  • [9] A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab
    Waller, Cornelius F.
    Vutikullird, Apinya
    Lawrence, Tracey E.
    Shaw, Andrew
    Liu, Mark Shiyao
    Baczkowski, Mark
    Sharma, Rajiv
    Barve, Abhijit
    Goyal, Parag
    Donnelly, Charles
    Sengupta, Nilanjan
    Pennella, Eduardo J.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (10) : 2336 - 2343
1